Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
Published: April 16, 2018 at 02:00AM
from NYT Health https://ift.tt/2qGky4b
Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
Published: April 16, 2018 at 02:00AM
from NYT Health https://ift.tt/2qGky4b